Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay

Journal of Immunological Methods

Volumn 377, Issue 1-2, 2012, Pages 37-46

  Whitelegg, Alison M E ^a   Birtwistle, Jane ^a   Richter, Alex ^a,b   Campbell, John P ^a   Turner, James E ^a   Ahmed, Tarana M ^a   Giles, Lynda J ^a   Fellows, Mark ^a   Plant, Tim ^a   Ferraro, Alastair J ^a,c   Cobbold, Mark ^a   Drayson, Mark T ^a   MacLennan, Calman A ^a,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Antibody; Bacterial; Flow cytometry; Immune deficiency; Multiplex; Vaccination

Indexed keywords

DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CROSS REACTION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGED; DIPHTHERIA TOXOID; FLOW CYTOMETRY; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MENINGOCOCCAL VACCINES; MIDDLE AGED; PNEUMOCOCCAL VACCINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TETANUS TOXOID; YOUNG ADULT;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE;

EID: 84857787038     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.01.007     Document Type: Article

References (36)

1. Balmer P., North J., Baxter D., Stanford E., Melegaro A., Kaczmarski E.B., Miller E., Borrow R. Measurement and interpretation of pneumococcal IgG levels for clinical management. Clin. Exp. Immunol. 2003, 133:364.
2. Balmer P., Borrow R., Findlow J., Warrington R., Frankland S., Waight P., George R., Andrews N., Miller E. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. Clin. Vaccine Immunol. 2007, 14:1442.
3. Baxendale H.E., Johnson M., Stephens R.C., Yuste J., Klein N., Brown J.S., Goldblatt D. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin. Exp. Immunol. 2008, 151:51.
4. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., Kobrynski L.J., Levinson A.I., Mazer B., Nelson R.P., Orange J.S., Routes J.M., Shearer W.T., Sorensen R.U. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 2005, 94:S1.
5. Borgers H., Moens L., Picard C., Jeurissen A., Raes M., Sauer K., Proesmans M., De B.K., Casanova J.L., Meyts I., Bossuyt X. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Clin. Immunol. 2010, 134:198.
6. Concepcion N.F., Frasch C.E. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 2001, 8:266.
7. de Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin. Exp. Immunol. 2006, 145:204.
8. Elberse K.E., Tcherniaeva I., Berbers G.A., Schouls L.M. Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine. Clin. Vaccine Immunol. 2010, 17:674.
9. Folds J.D., Schmitz J.L. 24. Clinical and laboratory assessment of immunity. J. Allergy Clin. Immunol. 2003, 111:S702-S711.
10. Hare N.D., Smith B.J., Ballas Z.K. Antibody response to pneumococcal vaccination as a function of preimmunization titer. J. Allergy Clin. Immunol. 2009, 123:195.
11. Hazlewood M., Nusrat R., Kumararatne D.S., Goodall M., Raykundalia C., Wang D.G., Joyce H.J., Milford-Ward A., Forte M., Pahor A. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin. Exp. Immunol. 1993, 93:157.
12. Holder P.K., Maslanka S.E., Pais L.B., Dykes J., Plikaytis B.D., Carlone G.M. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. Diagn. Lab. Immunol. 1995, 2:132.
13. Huo Z.M., Miles J., Riches P.G., Harris T. Limitations of Pneumovax as a detection antigen in the measurement of serotype-specific antibodies by enzyme-linked immunosorbent assay. Ann. Clin. Biochem. 2002, 39:398.
14. Jeurissen A., Moens L., Raes M., Wuyts G., Willebrords L., Sauer K., Proesmans M., Ceuppens J.L., De B.K., Bossuyt X. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin. Chem. 2007, 53:505.
15. Joseph H., Balmer P., Bybel M., Papa T., Ryall R., Borrow R. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera. Clin. Diagn. Lab. Immunol. 2004, 11:1.
16. Kayhty H., Peltola H., Karanko V., Makela P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 1983, 147:1100.
17. Lal G., Balmer P., Joseph H., Dawson M., Borrow R. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin. Diagn. Lab. Immunol. 2004, 11:272.
18. Lal G., Balmer P., Stanford E., Martin S., Warrington R., Borrow R. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J. Immunol. Methods 2005, 296:135.
19. Lankinen K.S., Rintamaki S., Syrjanen R., Kilpi T., Ruutu P., Leinonen M. Type-specific enzyme immunoassay for detection of pneumococcal capsular polysaccharide antigens in nasopharyngeal specimens. J. Microbiol. Methods 2004, 56:193.
20. Levine O.S., Knoll M.D., Jones A., Walker D.G., Risko N., Gilani Z. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Curr. Opin. Infect. Dis. 2010, 23:236.
21. Makela P.H., Kayhty H., Weckstrom P., Sivonen A., Renkonen O.V. Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet 1975, 2:883.
22. McCusker C., Somerville W., Grey V., Mazer B. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. Ann. Allergy Asthma Immunol. 1997, 79:145.
23. Paris K., Sorensen R.U. Assessment and clinical interpretation of polysaccharide antibody responses. Ann. Allergy Asthma Immunol. 2007, 99:462.
24. Peltola H., Makela H., Kayhty H., Jousimies H., Herva E., Hallstrom K., Sivonen A., Renkonen O.V., Pettay O., Karanko V., Ahvonen P., Sarna S. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 1977, 297:686.
25. Pickering J.W., Martins T.B., Greer R.W., Schroder M.C., Astill M.E., Litwin C.M., Hildreth S.W., Hill H.R. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am. J. Clin. Pathol. 2002, 117:589.
26. Pickering J.W., Martins T.B., Schroder M.C., Hill H.R. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin. Diagn. Lab. Immunol. 2002, 9:872.
27. Plotkin S.A. Immunologic correlates of protection induced by vaccination. Pediatr. Infect. Dis. J. 2001, 20:63.
28. Quataert S.A., Kirch C.S., Wiedl L.J., Phipps D.C., Strohmeyer S., Cimino C.O., Skuse J., Madore D.V. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 1995, 2:590.
29. Quataert S.A., Rittenhouse-Olson K., Kirch C.S., Hu B., Secor S., Strong N., Madore D.V. Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Clin. Diagn. Lab. Immunol. 2004, 11:1064.
30. Raby R., Blaiss M., Gross S., Herrod H.G. Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections. J. Allergy Clin. Immunol. 1996, 98:451.
31. Schauer U., Stemberg F., Rieger C.H., Buttner W., Borte M., Schubert S., Mollers H., Riedel F., Herz U., Renz H., Herzog W. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin. Diagn. Lab. Immunol. 2003, 10:202.
32. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., Klugman K.P., Madhi S.A., Paradiso P., Kohberger R. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 2007, 25:3816.
33. Spickett G.P., Askew T., Chapel H.M. Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases. Qual. Health Care 1995, 4:263.
34. Trotter C.L., Borrow R., Findlow J., Holland A., Frankland S., Andrews N.J., Miller E. Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era. Clin. Vaccine Immunol. 2008, 15:1694.
35. Wasserman R.L., Sorensen R.U. Evaluating children with respiratory tract infections: the role of immunization with bacterial polysaccharide vaccine. Pediatr. Infect. Dis. J. 1999, 18:157.
36. Wuorimaa T., Kayhty H., Eskola J., Bloigu A., Leroy O., Surcel H.M. Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine. Scand. J. Immunol. 2001, 53:422.